Top Story

ASH announces training program participants

ASH announces training program participants
May 24, 2015

ASH and the European Hematology Association released the names of 20 early-career hematologists who are participating in the 2015 Translational Research in Hematology joint program.

The TRTH program, in its sixth year, helps junior scientists build successful careers in hematologic translational research through a rigorous year-long training and mentoring experience. Participants include medical, biomedical and pharmaceutical doctorate trainees actively employed in a hematology-related research environment who are junior faculty or program leaders and have completed their fellowship training within the past 3 years.

FDA News

FDA grants fast track status to luspatercept for beta-thalassemia

May 18, 2015
The FDA granted fast track status to luspatercept for patients with transfusion- dependent beta-thalassemia and nontransfusion-dependent beta-thalassemia, according to a…

FDA issues draft guidance on blood donations from MSM

May 13, 2015
The FDA has formally recommended a proposal to allow men who have sex with men to donate blood, provided that their most recent sexual contact was at least 1 year…
In the Journals

Anemia, hemoglobin level decrease exercise capacity, QOL in patients with COPD

May 13, 2015
Anemia reduces exercise capacity and negatively impacts quality of life in patients with COPD, according to study results.Marcello Ferrari, MD, department of medicine…
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
Lowering Factor XI levels effective in prevention of venous thrombosis

Lowering Factor XI levels effective in prevention of venous thrombosis

December 11, 2014
SAN FRANCISCO – A late-breaking abstract presented at the ASH Annual Meeting and Exposition identified a novel…
More »
David A. Williams, MD Association News

ASH announces training program participants

May 24, 2015
ASH and the European Hematology Association released the names of 20 early-career hematologists who are participating in the 2015 Translational…
FDA News

FDA grants fast track status to luspatercept for beta-thalassemia

May 18, 2015
The FDA granted fast track status to luspatercept for patients with transfusion- dependent beta-thalassemia and nontransfusion-dependent…

FDA issues draft guidance on blood donations from MSM

May 13, 2015
The FDA has formally recommended a proposal to allow men who have sex with men to donate blood, provided that their most recent sexual contact was…
In the Journals

Anemia, hemoglobin level decrease exercise capacity, QOL in patients with COPD

May 13, 2015
Anemia reduces exercise capacity and negatively impacts quality of life in patients with COPD, according to study results.Marcello Ferrari, MD
In the Journals

Outpatient treatment safe for select patients with acute PE

May 7, 2015
Favorable short-term outcomes of patients with pulmonary embolisms after hospital discharge suggest these patients can safely receive outpatient…
In the Journals

Thrombotic events linked with increased mortality in patients with lupus anticoagulant

May 1, 2015
For individuals positive for lupus anticoagulant, the occurrence of a thrombotic event is linked with higher mortality, according to research…
In the Journals

Hydroxyurea may be underused for patients with sickle cell anemia

April 28, 2015
Less than a quarter of patients with sickle cell anemia and pain crises received hydroxyurea within 1 year of a third hospital or emergency…
In the JournalsPerspective

Vena cava filter as anticoagulation add-on did not reduce symptomatic recurrent pulmonary embolism

April 28, 2015
The risk for symptomatic recurrent pulmonary embolism does not appear to diminish among patients hospitalized for a life-threatening blood clot in…
FDA News

FDA grants priority review status for idarucizumab

April 23, 2015
Boehringer Ingelheim Pharmaceuticals Inc. announced that the FDA has granted priority review status for the company’s biologics license…
Genetic variant in platelet, more common in blacks, increases risk for clotting Meeting News Coverage

Genetic variant in platelet, more common in blacks, increases risk for clotting

April 22, 2015
A genetic variation in a receptor on the surface of a platelet could help explain differences in clotting risk, according to findings from research…
More Headlines »